Methods for nucleic acid isolation and kits using a microfluidic device and sedimenting reagent

• US 20050142570A1
• Filed: 05/24/2004
• Published: 06/30/2005
• Est. Priority Date: 12/24/2003
• Status: Abandoned Application

• Current Assignee: 3M Innovative Properties Company (3M Company)
• Original Assignee: 3M Innovative Properties Company (3M Company)
• Inventors: Bedingham, William, Parthasarathy, Ranjani V., Ericson, Katya
• Application Number:
  US10/852,022
• Publication Number:
  US 20050142570A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: B01L 2200/0605 Metering of fluids
• CPC Class Codes: B01L 2200/10 Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
• CPC Class Codes: B01L 2300/0803 Disc shape
• CPC Class Codes: B01L 2400/0409 centrifugal forces
• CPC Class Codes: B01L 2400/0677 phase change valves; Meltable, freezing, dissolvable plugs; Destructible barriers
• CPC Class Codes: B01L 3/502738 characterised by integrated valves microvalves F16K99/0001
• CPC Class Codes: B01L 3/502753 characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation separation in general B01D; microapparatus for analysis using electrophoresis G01N27/44791; sample preparation G01N1/28
• CPC Class Codes: C07H 21/04 with deoxyribosyl as saccharide radical
• CPC Class Codes: C12Q 1/6806 Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay C12Q1/6804 takes precedence
• CPC Class Codes: C12Q 2565/629 being a microfluidic device

Abstract

The present invention provides methods and kits for isolating nucleic acid from a sample, preferably from a biological sample, using a microfluidic device and sedimenting reagent.

Claims

1. A method of isolating nucleic acid from a sample, the method comprising:

providing a microfluidic device comprising a loading chamber, a valved process chamber, and a mixing chamber;

providing a sample comprising nucleic acid-containing material and inhibitors;

providing a sedimenting reagent;

placing the sample in the loading chamber;

transferring the sample to the valved process chamber;

forming a concentrated region of the sample in the valved process chamber using the sedimenting reagent, wherein the concentrated region of the sample comprises a majority of the nucleic acid-containing material and a less concentrated region of the sample comprises at least a portion of the sedimenting reagent and at least a portion of the inhibitors;

activating a valve in the valved process chamber to transfer at least a portion of the concentrated region of the sample to the mixing chamber and separate at least a portion of the concentrated region from the less concentrated region of the sample;

lysing the nucleic acid-containing material with optional heating in the mixing chamber to release nucleic acid; and

optionally adjusting the pH of the sample comprising released nucleic acid.

12. A kit for isolating nucleic acid from a sample, the kit comprising:

a sedimenting reagent;

a microfluidic device comprising a loading chamber, a valved process chamber, and a mixing chamber; and

instructions for lysing a sample and separating a majority of the nucleic acid-containing material from at least a portion of the inhibitors according to the method of claim 1.

2. A method of isolating nucleic acid from a sample, the method comprising:

providing a microfluidic device comprising a loading chamber, a valved process chamber, and a mixing chamber;

providing a sample comprising nucleic acid-containing material and cells containing inhibitors;

providing a sedimenting reagent;

placing the sample in the loading chamber;

transferring the sample to the valved process chamber;

forming a concentrated region of the sample in the valved process chamber using the sedimenting reagent, wherein the concentrated region of the sample comprises a majority of the nucleic acid-containing material and a less concentrated region of the sample comprises at least a portion of the sedimenting reagent and at least a portion of the inhibitors;

activating a valve in the valved process chamber to transfer at least a portion of the concentrated region of the sample to the mixing chamber and separate at least a portion of the concentrated region from the less concentrated region of the sample;

lysing the nucleic acid-containing material in the mixing chamber to release nucleic acid; and

optionally adjusting the pH of the sample comprising released nucleic acid.

3. The method of claim 2 wherein the sample is blood.

4. The method of claim 2 wherein the nucleic acid-containing material comprises nuclei

5. The method of claim 2 wherein the less concentrated region comprises a majority of the sedimenting reagent.

6. The method of claim 2 wherein the sample is a tissue extract.

7. The method of claim 2 further comprising transferring the sample comprising released nucleic acid to an amplification reaction chamber.

8. The method of claim 7 further comprising subjecting the released nucleic acid to an amplification process.

9. The method of claim 2 wherein forming a concentrated region of the sample in the valved process chamber comprises centrifuging the sample in the process chamber.

10. The method of claim 2 wherein prior to lysing the nucleic acid-containing material, the method comprises diluting the separated concentrated region of the sample with water or buffer, optionally further concentrating the diluted region to increase the concentration of nucleic acid material, optionally separating the further concentrated region, and optionally repeating this process of dilution followed by concentration and separation to reduce the inhibitor concentration to that which would not interfere with an amplification method.

11. The method of claim 2 wherein before, simultaneously with, or after lysing the nucleic acid-containing material, the method comprises transferring the separated concentrated region of the sample to a separation chamber for contact with solid phase material to preferentially adhere at least a portion of the inhibitors to the solid phase material;

wherein the solid phase material comprises capture sites, a coating reagent coated on the solid phase material, or both;

wherein the coating reagent is selected from the group consisting of a surfactant, a strong base, a polyelectrolyte, a selectively permeable polymeric barrier, and combinations thereof.

13. A kit for isolating nucleic acid from a sample, the kit comprising:

a sedimenting reagent;

a microfluidic device comprising a loading chamber, a valved process chamber, and a mixing chamber; and

instructions for lysing a sample and separating a majority of the nucleic acid-containing material from at least a portion of the inhibitors according to the method of claim 2.